Search results
Results from the WOW.Com Content Network
A 2011 review considered cannabis to be generally safe, [33] and it appears safer than opioids in palliative care. [34] A 2022 review concluded the pain relief experienced after using medical cannabis is due to the placebo effect, especially given widespread media attention that sets the expectation for pain relief. [35]
Δ-8-tetrahydrocannabinol (delta-8-THC, [a] Δ 8-THC) is a psychoactive cannabinoid found in the cannabis plant. [1] It is an isomer of delta-9-tetrahydrocannabinol (delta-9-THC, Δ 9-THC), the compound commonly known as THC, with which it co-occurs in hemp; natural quantities of ∆ 8-THC found in hemp are low.
Cannabis indica is an annual plant species in the family Cannabaceae [1] indigenous to the Hindu Kush mountains of Southern Asia. [2] The plant produces large amounts of tetrahydrocannabinol (THC) [ 3 ] and tetrahydrocannabivarin (THCV), with total cannabinoid levels being as high as 53.7%. [ 4 ]
An FDA advisory informs consumers of five things they should know about Delta 8 THC and possible health risks
Proposition 215 – the Compassionate Use Act of 1996 – was subsequently approved with 56% of the vote, legalizing the use, possession, and cultivation of cannabis by patients with a physician's recommendation, for treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or "any other illness for which ...
The academy has published new guidelines on the use of marijuana pills and sprays in the treatment of MS. [48] Cannabis is being investigated for its possible use in inflammatory bowel disease but as of 2014 there is only weak evidence for its benefits as a treatment. [49] A 2007 review said cannabidiol had shown potential to relieve convulsion ...
Oral cannabis extract and THC both were rated as possibly effective for improving objective measures of spasticity. [74] [75] Centrally mediated pain and painful spasms. Based on the results of 4 high quality trials and 4 low quality trials, oral cannabis extract was rated as effective, and THC as probably effective in treating central pain and ...
Nabiximols (brand name Sativex), an oromucosal spray made of a complex botanical mixture containing cannabidiol (CBD), delta-9-tetrahydrocannabinol (THC), and additional cannabinoid and non-cannabinoid constituents from cannabis sativa plants, was approved by Health Canada in 2005, to treat central neuropathic pain in multiple sclerosis, and in ...